Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce A Feinberg

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
JAMA Oncology|November 24, 2017
Challenges, Perceptions, and Readiness of Oncology Clinicians for the MACRA Quality Payment ProgramChadi Nabhan, Yolaine Jeune-Smith, Peter Klinefelter, et al.
JCO Oncology Practice|April 22, 2021
Expanded Access and Right To Try Requests: The Community Oncologist's ExperienceMarjorie E Zettler, Yolaine Jeune-Smith, Bruce A Feinberg, et al.
Journal of Oncology Practice|May 2, 2012
Hemoglobin trends and anemia treatment resulting from concomitant chemotherapy in community oncology clinicsBruce A Feinberg, Amanda S Bruno, Sally Haislip, et al.
Advances in Therapy|May 9, 2020
Lenvatinib and Subsequent Therapy for Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Real-World Study of Clinical Effectiveness in the United StatesJonathan K Kish, Debanjana Chatterjee, Yin Wan, et al.
The American Journal of Managed Care|October 27, 2018
Understanding total cost of care in advanced non-small cell lung cancer pre- and postapproval of immuno-oncology therapiesBeata Korytowsky, Janna Radtchenko, Esmond D Nwokeji, et al.
Journal of Geriatric Oncology|August 17, 2020
Real-world adverse events associated with CAR T-cell therapy among adults age ≥ 65 yearsMarjorie E Zettler, Bruce A Feinberg, Eli G Phillips, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 9, 2020
Use of Real-World Evidence to Support FDA Approval of Oncology DrugsBruce A Feinberg, Ajeet Gajra, Marjorie E Zettler, et al.
JAMA Network Open|February 25, 2021
Comparison of Solid Tumor Treatment Response Observed in Clinical Practice With Response Reported in Clinical TrialsBruce A Feinberg, Marjorie E Zettler, Andrew J Klink, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 27, 2024
Oncologist Perceptions of Racial Disparity, Racial Anxiety, and Unconscious Bias in Clinical Interactions, Treatment, and OutcomesAlexandrina Balanean, Emily Bland, Ajeet Gajra, et al.
The American Journal of Managed Care|October 18, 2019
Real-world outcomes among patients with early rapidly progressive rheumatoid arthritisAndrew J Klink, Tammy G Curtice, Kiran Gupta, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
JAMA Oncology|November 24, 2017
Challenges, Perceptions, and Readiness of Oncology Clinicians for the MACRA Quality Payment ProgramChadi Nabhan, Yolaine Jeune-Smith, Peter Klinefelter, et al.
JCO Oncology Practice|April 22, 2021
Expanded Access and Right To Try Requests: The Community Oncologist's ExperienceMarjorie E Zettler, Yolaine Jeune-Smith, Bruce A Feinberg, et al.
Journal of Oncology Practice|May 2, 2012
Hemoglobin trends and anemia treatment resulting from concomitant chemotherapy in community oncology clinicsBruce A Feinberg, Amanda S Bruno, Sally Haislip, et al.
Advances in Therapy|May 9, 2020
Lenvatinib and Subsequent Therapy for Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Real-World Study of Clinical Effectiveness in the United StatesJonathan K Kish, Debanjana Chatterjee, Yin Wan, et al.
The American Journal of Managed Care|October 27, 2018
Understanding total cost of care in advanced non-small cell lung cancer pre- and postapproval of immuno-oncology therapiesBeata Korytowsky, Janna Radtchenko, Esmond D Nwokeji, et al.
Journal of Geriatric Oncology|August 17, 2020
Real-world adverse events associated with CAR T-cell therapy among adults age ≥ 65 yearsMarjorie E Zettler, Bruce A Feinberg, Eli G Phillips, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 9, 2020
Use of Real-World Evidence to Support FDA Approval of Oncology DrugsBruce A Feinberg, Ajeet Gajra, Marjorie E Zettler, et al.
JAMA Network Open|February 25, 2021
Comparison of Solid Tumor Treatment Response Observed in Clinical Practice With Response Reported in Clinical TrialsBruce A Feinberg, Marjorie E Zettler, Andrew J Klink, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 27, 2024
Oncologist Perceptions of Racial Disparity, Racial Anxiety, and Unconscious Bias in Clinical Interactions, Treatment, and OutcomesAlexandrina Balanean, Emily Bland, Ajeet Gajra, et al.
The American Journal of Managed Care|October 18, 2019
Real-world outcomes among patients with early rapidly progressive rheumatoid arthritisAndrew J Klink, Tammy G Curtice, Kiran Gupta, et al.
Pageof 5